11/12/2024 - Press release
Consuming 20-30% of daily energy intake in the morning influences key cardiovascular risk factors. People who consume the right amount of energy in the morning have 2-3.5% lower body mass index, less abdominal obesity (2-4% smaller waist circumference), 9-18% lower triglycerides, and 4-8.5% higher HDL cholesterol (the good cholesterol). Additionally, having a high-quality breakfast with a balanced intake of proteins, high-value fats, fiber, calcium, and iron is associated with a 1.5% smaller waist circumference, 4% lower triglycerides, and 3% higher HDL cholesterol. The study tracked nearly 400 participants of the PREDIMED-Plus study over three years, which analyzes the effects of the Mediterranean diet on participants' health.
Més informació "Having a good breakfast reduces cardiovascular risk"
02/12/2024 - Press release
A study by the Hospital del Mar Research Institute, in collaboration with the University of Vic-Central University of Catalonia (UVic-UCC), published in the Revista Española de Cardiología, validates the effectiveness of this type of initiative. Implementing out-of-hospital care programs reduces the fatality rate of heart attacks by 35% and long-term mortality by 27%.
19/11/2024 - Press release
A scientific article by the PASOS consortium, led by the Gasol Foundation and the Hospital del Mar Research Institute, confirms that nearly 60% of children with overweight present abdominal obesity. 56.1% of the population aged 8 to 16 with overweight (based on BMI) has an excess of fat around the waist, a percentage that 20 years ago stood at 40%. Abdominal obesity is associated with visceral fat, a condition defining cardiometabolic risk, which already affects more than 1 million children aged 8 to 16 in Spain. The PASOS study by the Gasol Foundation continues to contribute to scientific evidence and understanding the issue of childhood obesity.
06/03/2024 - Press release
Between 1990 and 2019, the incidence of myocardial infarction in the Girona area decreased by 1% in women and 4% in men each year in the population aged 35 to 74 years, while, in the last 10 years, its lethality, the number of people who die 28 days after the onset of symptoms, has remained stagnant at around 15%. Data from almost five million hospital admissions and more than 70,000 death certificates have been analyzed as part of the REGICOR study, Registre Gironí del COR. These data suggest that primary prevention and rapidity of care have contributed to reducing the incidence of infarction and sudden death, increasing the chances of survival among patients arriving at the hospital.
Més informació "Decline in the mortality rate of people who suffer myocardial infarction stalls"
28/02/2024 - Covid-19
One of them is related to heart disease, according to the CARGENCORS study. The work has allowed finding a significant association of new genetic variants previously related to heart disease, thrombosis, inflammation, with the severity of COVID-19 in more than 3000 COVID-19 patients in the area of Barcelona and Girona. People with these variants have a 10-60% increased chance of developing severe disease. The CARGENCORS (CARdiovascular GENEtic risk score for Risk Stratification of patients positive for SARS-CoV-2 (COVID-19) virus) study has established a direct link between some of the genetic factors that increase the risk of heart disease and the severity of COVID-19. The work, published in the Journal of Medical Virology, marks a further step towards understanding the mechanisms of COVID-19 severity through susceptibility in heart disease.
Més informació "New genetic variants related to severe COVID-19 identified"
30/01/2024 - Press release
This is revealed by the largest observational study in this field carried out to date in the world. It is published in the journal Nutrients. The work is based on data from the UK Biobank database and has made it possible to analyze information from more than 260,000 people. Its conclusions may allow a more detailed definition of future studies on omega-3 supplementation for the prevention of dementia. The potential benefits of these fatty acids are maximal in men over 60 and in dementias other than Alzheimer's disease.
28/12/2023 - Press release
An observational study conducted by researchers from Pompeu Fabra University and Hospital del Mar determines that the intradermal administration of the JYNNEOS vaccine against smallpox induces an efficient immune response that should protect people living with HIV from contracting the monkeypox virus.
People with HIV have altered levels of a specific RNA molecule related to both aging and inflammation. This molecule remains altered even with antiretroviral treatment, indicating that their immune system remains affected despite receiving antiretroviral treatment and controlling the infection. The authors of the study, published in the Journal of Microbiology, Immunology, and Infection, suggest that the origin of this alteration is chronic inflammation caused by the infection, regardless of the treatment received by patients. Having this marker can be helpful in monitoring the evolution of patients and the effectiveness of the drugs they take to restore the normal functioning of their immune system.
Researchers from the Hospital del Mar Research Institute have published a new article in Microbiology Spectrum proposing a novel approach to treating pneumonia caused by antibiotic-resistant Pseudomonas aeruginosa bacteria. The study suggests that increasing the dose of the antibiotic colistin may not only be ineffective, but could also increase patient mortality. For this reason, the researchers advocate for using nebulized administration of the treatment instead of intravenous administration. This approach achieves higher concentrations in the lungs, where the infection is located, without causing toxic colistin concentrations in the blood. The World Health Organization considers antibiotic resistance among the top 10 global public health threats.
15/11/2023 - Institutional news
Evidence shows an annual loss of 34.6 million life-years globally due to suicide. In response to this, globally renowned institutions specialized in mental health and suicide research, in collaboration with experts in bioinformatics, have launched PERMANENS, a pioneering European research initiative. The PERMANENS research project is dedicated to create a medical software prototype that supports clinicians in delivering personalized assessments and care to patients arriving at the emergency department with an elevated risk of self-harm or suicide. This precision medicine software will harness the power of artificial intelligence to provide more accurate risk assessments and access to evidence-based information, enabling the identification of effective treatment options tailored to each patient's unique needs and risk profile.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
